Clinical Trial Update: MYLUNG Consortium Part 3: Observational Study

View source ↗

Summary

This document reports a recruiting observational study in the MYLUNG Consortium Part 3 focusing on non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: US Oncology Research | Conditions: Carcinoma, Non-Small-Cell Lung | Status: RECRUITING